BE856351A - Procede de preparation d'une souche mutante virale avirulente a partir du virus d'aujeszky - Google Patents

Procede de preparation d'une souche mutante virale avirulente a partir du virus d'aujeszky

Info

Publication number
BE856351A
BE856351A BE2056044A BE2056044A BE856351A BE 856351 A BE856351 A BE 856351A BE 2056044 A BE2056044 A BE 2056044A BE 2056044 A BE2056044 A BE 2056044A BE 856351 A BE856351 A BE 856351A
Authority
BE
Belgium
Prior art keywords
preparing
mutant strain
viral mutant
aujeszky virus
avirulent
Prior art date
Application number
BE2056044A
Other languages
English (en)
Inventor
G M Tatarov
Original Assignee
Dso Pharmachim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dso Pharmachim filed Critical Dso Pharmachim
Publication of BE856351A publication Critical patent/BE856351A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE2056044A 1976-07-02 1977-07-01 Procede de preparation d'une souche mutante virale avirulente a partir du virus d'aujeszky BE856351A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG3365276 1976-07-02

Publications (1)

Publication Number Publication Date
BE856351A true BE856351A (fr) 1977-10-31

Family

ID=3902412

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2056044A BE856351A (fr) 1976-07-02 1977-07-01 Procede de preparation d'une souche mutante virale avirulente a partir du virus d'aujeszky

Country Status (7)

Country Link
AR (1) AR216081A1 (fr)
BE (1) BE856351A (fr)
CA (1) CA1069821A (fr)
ES (1) ES460321A1 (fr)
FR (1) FR2356726A1 (fr)
GB (1) GB1563284A (fr)
NL (1) NL7707341A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2484446A1 (fr) * 1980-06-12 1981-12-18 Asta Werke Ag Chem Fab Procede pour la preparation de nouveaux mutants de virus de l'herpes, type 1 et type 2, mutants obtenus et leur application a la fabrication de vaccins contre les infections herpetiques

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187421B (en) * 1982-10-27 1986-01-28 Phylaxia Oltoanyagtermeloe Vallalat,Hu Process for producing inactivated, adjuvated serum against aujeszky's illness
US4514497B1 (en) * 1983-12-30 1998-02-24 Novagene Inc Modified live pseudorabies viruses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2484446A1 (fr) * 1980-06-12 1981-12-18 Asta Werke Ag Chem Fab Procede pour la preparation de nouveaux mutants de virus de l'herpes, type 1 et type 2, mutants obtenus et leur application a la fabrication de vaccins contre les infections herpetiques

Also Published As

Publication number Publication date
ES460321A1 (es) 1978-11-01
FR2356726B1 (fr) 1981-01-16
FR2356726A1 (fr) 1978-01-27
CA1069821A (fr) 1980-01-15
NL7707341A (nl) 1978-01-04
AR216081A1 (es) 1979-11-30
GB1563284A (en) 1980-03-26

Similar Documents

Publication Publication Date Title
FR2418027B1 (fr) Procede de preparation d'une electrode
FR2353503A1 (fr) Procede de preparation d'un materiau en ceramique
FR2319422A1 (fr) Procede de preparation d'un catalyseur supporte de ziegler
FR2314915A1 (fr) Procede de preparation du 2-hydroxyisobutyramide a partir de l'acetone-cyanhydrine
FR2338239A1 (fr) Procede de preparation du 4,4'-isopropylidene-bis(2,6-dibromophenol)
BE861020A (fr) Procede de preparation de n-imides a partir d'acides amiques
FR2347345A1 (fr) Procede de preparation d'alkylthiomethylphenols
BE856351A (fr) Procede de preparation d'une souche mutante virale avirulente a partir du virus d'aujeszky
FR2353512A1 (fr) Procede de preparation d'acetals
BE842940A (fr) Procede de preparation d'oxaphospholannes-1,2,
FR2341529A1 (fr) Procede de preparation de b''-a12o3
BE865728A (fr) Procede de preparation du 2,3-dimethylpentanal
FR2455568B1 (fr) Procede de preparation du 2,3-dimethylbutene-2
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
FR2335505A1 (fr) Procede de preparation de gamma-butyrolactones a partir d'olefines
FR2338939A1 (fr) Procede de preparation de (vinyl 2, 2-disubstitue)-g-butyrolactones
BE874638A (fr) Procede de preparation d'une 1,2-dioxime
LU80262A1 (fr) Procede de preparation de 10,11-dihydro-5h-dibenzo(a,d)cycloheptene-5,10-imines substituees en position 5
FR2341574A1 (fr) Procede de preparation d'une gamma-lactone
BE844433A (fr) Procede de preparation de chloro-2 butadiene-1,3
RO77442A (fr) Procede de preparation des octahydro-2h-pyrolo(3,4-g) quinoleines
FR2344564A2 (fr) Procede de preparation de 2,5-dioxo-1,2-oxa-phospholannes
BE853815A (fr) Procede de preparation de copolymeres de l'ethylene
BE878318A (fr) Procede de preparation de 1,2-polybutadiene
BE844269A (fr) Procede de preparation de l'anthraquinone a partir de la tetrahydroanthaquinone

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DSO PHARMACHIM

Effective date: 19860731